Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erectus nerve block for lumbar spine surgery: a prospective randomized study
2019-001678-26Phase 3Completed
- Sponsor
- CHU Nîmes
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ropivacaine in Lumbar Spinal Disease, lumbar spondylosis and lumbosacral disc disease (2 arms), sponsored by CHU Nîmes. Started May 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
Lumbar Spinal Diseaselumbar spondylosislumbosacral disc disease
Beyond the preview
Go deeper on 2019-001678-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001678-26.